
Profound Medical Corp. PROF
€ 6.10
6.87%
Geschäftsbericht 2023
hinzugefügt 27.12.2025
Profound Medical Corp. Gesamtverbindlichkeiten 2011-2026 | PROF
Gesamtverbindlichkeiten Jährlich Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.7 M | 12.4 M | 6.16 M | 7.25 M | - | - | 13.7 M | 6.59 M | 5.21 M | 103 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.7 M | 103 K | 8.02 M |
Gesamtverbindlichkeiten Vierteljährlich Profound Medical Corp.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 6.16 M | - | - | - | 7.25 M | - | - | - | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.7 M | 6.16 M | 9.7 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.13 | -1.39 % | $ 1.29 M | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 11.44 | 3.81 % | $ 410 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
10.6 M | $ 25.21 | -1.6 % | $ 213 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
27.2 M | $ 3.49 | 4.49 % | $ 131 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 46.15 | -15.91 % | $ 1.36 B | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.25 | 0.63 % | $ 319 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 57.82 | -2.12 % | $ 3.15 B | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.63 | 0.87 % | $ 39.2 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.07 | -1.38 % | $ 18.1 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 169.07 | -1.35 % | $ 11.9 B | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.05 | 1.71 % | $ 377 M | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.38 | 0.42 % | $ 6.6 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.96 | 2.37 % | $ 1.05 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
730 M | $ 91.09 | 0.54 % | $ 12.3 B | ||
|
NanoVibronix
NAOV
|
7.63 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.07 | 0.45 % | $ 1.12 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 86.83 | 3.36 % | $ 3.02 B | ||
|
TransMedics Group
TMDX
|
595 M | $ 96.34 | -0.76 % | $ 3.27 B | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 295.54 | 1.54 % | $ 113 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 19.25 | -3.12 % | $ 1.31 B | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 82.79 | -0.65 % | $ 48.4 B | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.51 | -0.9 % | $ 65.9 M | ||
|
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.26 | -5.26 % | $ 51.3 M | ||
|
MiMedx Group
MDXG
|
86.1 M | $ 3.71 | 2.77 % | $ 548 M | ||
|
Myomo
MYO
|
27.2 M | $ 0.85 | -1.1 % | $ 35.6 M |